Edit Content

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Transdermal Drug Delivery Systems Market to reach USD 145.43 billion by the end of 2030

Global Transdermal Drug Delivery Systems Market Size study & Forecast, by Technology (Electroporation, Radio Frequency, Iontophoresis, Microporation , Thermal, Mechanical arrays, Ultrasound, Others) by Application (CNS, Pain Management, Cardiovascular, Hormone, Immunological, Metabolic, Gastrointestinal, Infection, Cancer, Others) and Regional Analysis, 2023-2030

Product Code: HLSMDE-16021002
Publish Date: 20-02-2024
Page: 200

Global Transdermal Drug Delivery Systems Market is valued approximately at USD 59.16 billion in 2022 and is anticipated to grow with a growth rate of more than 11.90% over the forecast period 2023-2030. Transdermal drug delivery systems are a devices for administering medications through the skin, allowing drugs to be absorbed into the bloodstream directly from the application site. These systems typically involve the use of patches or topical formulations containing the drug, which gradually releases the medication over time. Transdermal delivery offers several advantages, including sustained release of drugs, improved patient compliance, avoidance of gastrointestinal degradation, and reduced risk of side effects compared to oral administration. The Transdermal Drug Delivery Systems market is expanding because of factors such as increasing incidence of chronic diseases, growing Geriatric Population and cohesive government initiatives promoting the development and use of transdermal drug delivery systems.

The increasing prevalence of chronic conditions such as cardiovascular diseases, diabetes, and pain-related disorders has boosted the demand for sustained and controlled drug delivery, which transdermal patches can provide. Thus, rising prevalence of chronic disease is driving the market growth. The International Diabetes Federation stated that India has an anticipated 74,194.7 thousand cases of diabetes in 2021, and that figure is expected to increase to 92,973.7 thousand cases by 2030. Furthermore, the Robert Wood Johnson Foundation reports that there were 157 million cases of chronic illness in the United States in 2020, with an expected rise to 171 million cases by 2030. Furthermore, International Agency for Research on Cancer (IARC), estimated that by year 2040 there would be around 27.5 million new cases across the globe from 1.9 million new cases in year 2021. In addition, Ongoing research and development activities and rising investment in healthcare industry are some factors creating new opportunities to the market growth. However, availability of alternatives systems stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Transdermal Drug Delivery Systems Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share. The expansion of this region’s market is primarily propelled by the expiration of patents, leading to an influx of new companies. Furthermore, the repositioning of previously unsuccessful drugs, the reformulation of existing compounds, and substantial investments from both established and emerging market participants have notably contributed to the significant market presence in this region. Asia Pacific is expected to grow significantly with fastest CAGR during the forecast period. This trend can be attributed to the increasing healthcare expenditure and the swift evolution of healthcare infrastructure. Furthermore, the expansion is fueled by the elevated focus on research and development and the rising awareness in emerging economies like China and India.

Major market player included in this report are:
Novartis AG
Johnson & Johnson
Mylan Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
Hisamitsu Pharmaceutical co. Inc
3M Company
Noven Pharmaceuticals, Inc.
4P Therapeutics, LLC
Grünenthal GmbH
AbbVie Inc

Recent Developments in the Market:
Ø In September 2023, Satio achieved a significant milestone in its journey with funding from ARPA-H. This investment underscores the company’s focus on advancing SatioRx, a pioneering transdermal drug delivery device tailored for home use and remote management.
Ø In September 2022, Biomind Labs and Queen’s University of Belfast obtained a controlled substances license, paving the way for the initiation of production for an innovative transdermal drug delivery system.
Global Transdermal Drug Delivery Systems Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Technology, Application, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:
Radio Frequency
Mechanical arrays

By Application:
Pain Management

By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Transdermal Drug Delivery Systems Market, by region, 2020-2030 (USD Billion)
1.2.2. Transdermal Drug Delivery Systems Market, by Technology, 2020-2030 (USD Billion)
1.2.3. Transdermal Drug Delivery Systems Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Transdermal Drug Delivery Systems Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Transdermal Drug Delivery Systems Market Dynamics
3.1. Transdermal Drug Delivery Systems Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Increasing incidence of chronic diseases Growing geriatric population Government initiatives promoting the development and use of transdermal drug delivery systems
3.1.2. Market Challenges High Cost of Transdermal Drug Delivery Systems Regulatory Challenges
3.1.3. Market Opportunities Ongoing research and development activities Rising investment in healthcare industry
Chapter 4. Global Transdermal Drug Delivery Systems Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Transdermal Drug Delivery Systems Market, by Technology
5.1. Market Snapshot
5.2. Global Transdermal Drug Delivery Systems Market by Technology, Performance – Potential Analysis
5.3. Global Transdermal Drug Delivery Systems Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
5.4. Transdermal Drug Delivery Systems Market, Sub Segment Analysis
5.4.1. Electroporation
5.4.2. Radio Frequency
5.4.3. Iontophoresis
5.4.4. Microporation
5.4.5. Thermal
5.4.6. Mechanical arrays
5.4.7. Ultrasound
5.4.8. Others
Chapter 6. Global Transdermal Drug Delivery Systems Market, by Application
6.1. Market Snapshot
6.2. Global Transdermal Drug Delivery Systems Market by Application, Performance – Potential Analysis
6.3. Global Transdermal Drug Delivery Systems Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Transdermal Drug Delivery Systems Market, Sub Segment Analysis
6.4.1. CNS
6.4.2. Pain Management
6.4.3. Cardiovascular
6.4.4. Hormone
6.4.5. Immunological
6.4.6. Metabolic
6.4.7. Gastrointestinal
6.4.8. Infection
6.4.9. Cancer
6.4.10. Others
Chapter 7. Global Transdermal Drug Delivery Systems Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Transdermal Drug Delivery Systems Market, Regional Market Snapshot
7.4. North America Transdermal Drug Delivery Systems Market
7.4.1. U.S. Transdermal Drug Delivery Systems Market Technology breakdown estimates & forecasts, 2020-2030 Application breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Transdermal Drug Delivery Systems Market
7.5. Europe Transdermal Drug Delivery Systems Market Snapshot
7.5.1. U.K. Transdermal Drug Delivery Systems Market
7.5.2. Germany Transdermal Drug Delivery Systems Market
7.5.3. France Transdermal Drug Delivery Systems Market
7.5.4. Spain Transdermal Drug Delivery Systems Market
7.5.5. Italy Transdermal Drug Delivery Systems Market
7.5.6. Rest of Europe Transdermal Drug Delivery Systems Market
7.6. Asia-Pacific Transdermal Drug Delivery Systems Market Snapshot
7.6.1. China Transdermal Drug Delivery Systems Market
7.6.2. India Transdermal Drug Delivery Systems Market
7.6.3. Japan Transdermal Drug Delivery Systems Market
7.6.4. Australia Transdermal Drug Delivery Systems Market
7.6.5. South Korea Transdermal Drug Delivery Systems Market
7.6.6. Rest of Asia Pacific Transdermal Drug Delivery Systems Market
7.7. Latin America Transdermal Drug Delivery Systems Market Snapshot
7.7.1. Brazil Transdermal Drug Delivery Systems Market
7.7.2. Mexico Transdermal Drug Delivery Systems Market
7.8. Middle East & Africa Transdermal Drug Delivery Systems Market
7.8.1. Saudi Arabia Transdermal Drug Delivery Systems Market
7.8.2. South Africa Transdermal Drug Delivery Systems Market
7.8.3. Rest of Middle East & Africa Transdermal Drug Delivery Systems Market

Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Novartis AG Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
8.3.2. Johnson & Johnson
8.3.3. Mylan Pharmaceuticals, Inc.
8.3.4. Boehringer Ingelheim GmbH
8.3.5. Hisamitsu Pharmaceutical co. Inc
8.3.6. 3M Company
8.3.7. Noven Pharmaceuticals, Inc.
8.3.8. 4P Therapeutics, LLC
8.3.9. Grünenthal GmbH
8.3.10. AbbVie Inc
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now